Multiple Assemblies exist for SMTL entry 6vlt
Crystal Structure of Human P450 2C9*2 Genetic Variant in Complex with Losartan; X-RAY DIFFRACTION 3.12 Å

	SMTL ID 6vlt.1 Ligands PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.2 Ligands PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.3 Ligands PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.4 Ligands PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.5 Ligands 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE; PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol; SULFATE ION Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.6 Ligands 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE; PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol; SULFATE ION Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.7 Ligands 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE; PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol; SULFATE ION Polypeptides Cytochrome P450 2C9 Oligo-state monomer
	SMTL ID 6vlt.8 Ligands 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE; PROTOPORPHYRIN IX CONTAINING FE; [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Polypeptides Cytochrome P450 2C9 Oligo-state monomer